ES518723A0 - Procedimiento para la preparacion de derivados de 4-oxo-2-acetidinil-butanoato. - Google Patents

Procedimiento para la preparacion de derivados de 4-oxo-2-acetidinil-butanoato.

Info

Publication number
ES518723A0
ES518723A0 ES518723A ES518723A ES518723A0 ES 518723 A0 ES518723 A0 ES 518723A0 ES 518723 A ES518723 A ES 518723A ES 518723 A ES518723 A ES 518723A ES 518723 A0 ES518723 A0 ES 518723A0
Authority
ES
Spain
Prior art keywords
acetidinyl
oxo
procedure
preparation
butanoate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES518723A
Other languages
English (en)
Other versions
ES8501747A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of ES518723A0 publication Critical patent/ES518723A0/es
Publication of ES8501747A1 publication Critical patent/ES8501747A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/18Oxygen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES518723A 1981-12-30 1982-12-30 Procedimiento para la preparacion de derivados de 4-oxo-2-acetidinil-butanoato. Expired ES8501747A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU814015A HU185491B (en) 1981-12-30 1981-12-30 Process for producing new azabicyclo-bracket-3.2.0-bracket closedheptane derivatives

Publications (2)

Publication Number Publication Date
ES518723A0 true ES518723A0 (es) 1984-12-16
ES8501747A1 ES8501747A1 (es) 1984-12-16

Family

ID=10966521

Family Applications (1)

Application Number Title Priority Date Filing Date
ES518723A Expired ES8501747A1 (es) 1981-12-30 1982-12-30 Procedimiento para la preparacion de derivados de 4-oxo-2-acetidinil-butanoato.

Country Status (17)

Country Link
JP (1) JPS58118587A (es)
AT (1) AT376982B (es)
BE (1) BE895492A (es)
CA (1) CA1190931A (es)
DE (1) DE3248676A1 (es)
ES (1) ES8501747A1 (es)
FI (1) FI824520L (es)
FR (1) FR2519001B1 (es)
GB (1) GB2114124A (es)
GR (1) GR77070B (es)
HU (1) HU185491B (es)
IT (1) IT1210970B (es)
LU (1) LU84569A1 (es)
NL (1) NL8205067A (es)
PL (1) PL239888A1 (es)
SE (1) SE8207478L (es)
ZA (1) ZA829596B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5625110A (en) * 1978-12-18 1981-03-10 Bristol Myers Co Antibacterial
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
JPS57176982A (en) * 1981-04-24 1982-10-30 Shionogi & Co Ltd Dioxolanylazetidinone compound, its preparation and use

Also Published As

Publication number Publication date
PL239888A1 (en) 1984-01-02
HU185491B (en) 1985-02-28
BE895492A (fr) 1983-06-28
JPS58118587A (ja) 1983-07-14
FI824520L (fi) 1983-07-01
FI824520A0 (fi) 1982-12-30
ATA450882A (de) 1984-06-15
DE3248676A1 (de) 1983-07-07
FR2519001B1 (fr) 1985-10-25
FR2519001A1 (fr) 1983-07-01
AT376982B (de) 1985-01-25
GB2114124A (en) 1983-08-17
SE8207478D0 (sv) 1982-12-29
IT1210970B (it) 1989-09-29
SE8207478L (sv) 1983-07-01
IT8225063A0 (it) 1982-12-30
CA1190931A (en) 1985-07-23
NL8205067A (nl) 1983-07-18
LU84569A1 (fr) 1984-10-22
GR77070B (es) 1984-09-05
ZA829596B (en) 1983-10-26
ES8501747A1 (es) 1984-12-16

Similar Documents

Publication Publication Date Title
ES520180A0 (es) Procedimiento para la preparacion de nuevos derivados de la aminometil-5-aril-3-oxazolidinona-2.
ES517167A0 (es) Procedimiento para la preparacion de nuevos bencimidazoles sustituidos.
ES511955A0 (es) "procedimiento para la preparacion de derivados de cefem".
ES517758A0 (es) Procedimiento para la preparacion de derivados de benzazepina.
ES514795A0 (es) Procedimiento para la preparacion de derivados substituidos de la piridazina.
ES521871A0 (es) Procedimiento para la preparacion de nuevos benzo-heterociclos.
ES524185A0 (es) Procedimiento para la preparacion de nuevos derivados de pirimidina o s-triacina.
ES504791A0 (es) Procedimiento para la preparacion de derivados de caprolactama.
ES514887A0 (es) Procedimiento para la preparacion de derivados de la piridazina.
ES538464A0 (es) Procedimiento para la preparacion de derivados de acilamida.
ES516863A0 (es) Procedimiento para la preparacion de derivados de penem.
ES513792A0 (es) Procedimiento para la preparacion de amidobenzamidas.
ES517030A0 (es) Procedimiento para la preparacion de derivados de eburnamonina.
MX156087A (es) Procedimiento para la preparacion de derivados de piperazino-2-pirimidinas
MX157777A (es) Procedimiento para la preparacion de derivados de ascoclorina
AR240460A1 (es) Procedimeitno para la preparacion de derivados de antraciclina.
ES518271A0 (es) Procedimiento para la preparacion de derivados de tiazolina.
ES513619A0 (es) "procedimiento para la preparacion de derivados de 1-azolil-2-hidroxi-alcano".
ES517292A0 (es) Procedimiento para la preparacion de eteres 1-fenil-3-triazolil-vinilicos substituidos.
ES517288A0 (es) Procedimiento para la preparacion de derivados de azolil-penteno.
ES513392A0 (es) Procedimiento para la obtencion de derivados de 2-amino-piridina sustituidos.
ES517153A0 (es) Procedimiento para la preparacion de nuevas acinorrifamicinas.
ES520537A0 (es) Procedimiento para la preparacion de derivados de carbaciclina.
ES518858A0 (es) Procedimiento para la fabricacion de derivados de tetrahidrobenzotiazol.
ES517888A0 (es) Procedimiento para la preparacion de tioalcanoil-carnitinas.